232 related articles for article (PubMed ID: 29331845)
1. Effect of levetiracetam on extracellular amino acid levels in the dorsal hippocampus of rats with temporal lobe epilepsy.
Pichardo Macías LA; Ramírez Mendiola BA; Contreras García IJ; Zamudio Hernández SR; Chávez Pacheco JL; Sánchez Huerta KB; Mendoza Torreblanca JG
Epilepsy Res; 2018 Feb; 140():111-119. PubMed ID: 29331845
[TBL] [Abstract][Full Text] [Related]
2. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
3. Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection.
Ueda Y; Doi T; Nagatomo K; Tokumaru J; Takaki M; Willmore LJ
Brain Res; 2007 Jun; 1151():55-61. PubMed ID: 17408599
[TBL] [Abstract][Full Text] [Related]
4. The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy.
Lévesque M; Behr C; Avoli M
Seizure; 2015 Feb; 25():18-25. PubMed ID: 25645630
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats.
Ahmad S; Fowler LJ; Whitton PS
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):1-8. PubMed ID: 15660242
[TBL] [Abstract][Full Text] [Related]
6. Chronic treatment with levetiracetam reverses deficits in hippocampal LTP in vivo in experimental temporal lobe epilepsy rats.
Ge YX; Tian XZ; Lin YY; Liu XY
Neurosci Lett; 2016 Aug; 628():194-200. PubMed ID: 27345386
[TBL] [Abstract][Full Text] [Related]
7. Effect of levetiracetam on DNA oxidation and glutathione content in a temporal lobe epilepsy model.
Contreras-García IJ; Bandala C; Ignacio-Mejía I; Pichardo-Macías LA; Mendoza-Torreblanca JG; García-Cruz ME; Gómez-Manzo S; Cárdenas-Rodríguez N
Acta Neurobiol Exp (Wars); 2024 Mar; 84(1):51-58. PubMed ID: 38587324
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of levetiracetam on hippocampal CA1 synaptic plasticity and molecular changes in the dentate gyrus in epileptic rats.
Salaka RJ; Nair KP; Sasibhushana RB; Udayakumar D; Kutty BM; Srikumar BN; Shankaranarayana Rao BS
Neurochem Int; 2022 Sep; 158():105378. PubMed ID: 35753511
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids.
Ahmad S; Fowler LJ; Whitton PS
Epilepsy Res; 2005 Feb; 63(2-3):141-9. PubMed ID: 15777732
[TBL] [Abstract][Full Text] [Related]
10. Changes in the Dentate Gyrus Gene Expression Profile Induced by Levetiracetam Treatment in Rats with Mesial Temporal Lobe Epilepsy.
Diaz-Villegas V; Pichardo-Macías LA; Juárez-Méndez S; Ignacio-Mejía I; Cárdenas-Rodríguez N; Vargas-Hernández MA; Mendoza-Torreblanca JG; Zamudio SR
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338984
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats.
Margineanu DG; Matagne A; Kaminski RM; Klitgaard H
Brain Res Bull; 2008 Nov; 77(5):282-5. PubMed ID: 18722515
[TBL] [Abstract][Full Text] [Related]
12. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model.
Sanon NT; Gagné J; Wolf DC; Aboulamer S; Bosoi CM; Simard A; Messiet E; Desgent S; Carmant L
Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status epilepticus.
Santana-Gómez CE; Valle-Dorado MG; Domínguez-Valentín AE; Hernández-Moreno A; Orozco-Suárez S; Rocha L
Neurochem Int; 2018 Nov; 120():224-232. PubMed ID: 30213635
[TBL] [Abstract][Full Text] [Related]
14. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy.
Ueda Y; Doi T; Takaki M; Nagatomo K; Nakajima A; Willmore LJ
Brain Res; 2009 Apr; 1266():1-7. PubMed ID: 19268434
[TBL] [Abstract][Full Text] [Related]
16. An interaction study of Ocimum sanctum L. and levetiracetam in pentylenetetrazole kindling model of epilepsy.
Sarangi SC; Pattnaik SS; Katyal J; Kaleekal T; Dinda AK
J Ethnopharmacol; 2020 Mar; 249():112389. PubMed ID: 31739106
[TBL] [Abstract][Full Text] [Related]
17. Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.
Contreras-García IJ; Gómez-Lira G; Phillips-Farfán BV; Pichardo-Macías LA; García-Cruz ME; Chávez-Pacheco JL; Mendoza-Torreblanca JG
Brain Sci; 2021 Apr; 11(5):. PubMed ID: 33922424
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats.
Ahmad S; Fowler LJ; Whitton PS
Brain Res; 2004 Dec; 1029(1):41-7. PubMed ID: 15533314
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis.
Smolders I; Khan GM; Manil J; Ebinger G; Michotte Y
Br J Pharmacol; 1997 Jul; 121(6):1171-9. PubMed ID: 9249254
[TBL] [Abstract][Full Text] [Related]
20. Development of tolerance to levetiracetam in rats with chronic epilepsy.
van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA
Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
